KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestMortgage LoansNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesReal Estate - NetRetained EarningsShareholder's EquityTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Mortgage Loans (2019 - 2026)

Sabra Health Care REIT has reported Mortgage Loans over the past 8 years, most recently at $432.9 million for Q1 2026.

  • For Q1 2026, Mortgage Loans fell 2.53% year-over-year to $432.9 million; the TTM value through Mar 2026 reached $432.9 million, down 2.53%, while the annual FY2025 figure was $434.1 million, 1.92% down from the prior year.
  • Mortgage Loans for Q1 2026 was $432.9 million at Sabra Health Care REIT, roughly flat from $434.1 million in the prior quarter.
  • Over five years, Mortgage Loans peaked at $444.2 million in Q1 2025 and troughed at $390.3 million in Q3 2022.
  • A 5-year average of $423.1 million and a median of $422.5 million in 2024 define the central range for Mortgage Loans.
  • Biggest five-year swings in Mortgage Loans: surged 292.27% in 2022 and later fell 2.53% in 2026.
  • Year by year, Mortgage Loans stood at $411.4 million in 2022, then increased by 2.24% to $420.6 million in 2023, then increased by 5.22% to $442.6 million in 2024, then decreased by 1.92% to $434.1 million in 2025, then fell by 0.27% to $432.9 million in 2026.
  • Business Quant data shows Mortgage Loans for SBRA at $432.9 million in Q1 2026, $434.1 million in Q4 2025, and $436.5 million in Q3 2025.